期刊文献+

卡他莫拉菌耐药性与β内酰胺酶分型 被引量:6

Antibacterial agents resistance and typing of β-lactamases in moraxella catarrhalis
原文传递
导出
摘要 目的对卡他莫拉菌BROβ内酰胺酶进行分型分析,并对其与抗菌药物耐药的关系进行探讨。方法采用BSAC(britishsocietyforantimicrobialchemotherapy,BSAC)琼脂稀释法对本院呼吸道感染患儿鼻咽部分离的80株卡他莫拉菌株进行8种药敏试验,用Nitrocefin纸片检测β内酰胺酶,采用限制性内切酶分析方法进行bro基因分型,同时将bro1基因阳性和bro2基因阳性菌株对β内酰胺类抗菌药物的耐药性进行比较。结果(1)80株卡他莫拉菌β内酰胺酶阳性率为95.0%。对氨苄西林MIC90为32μg/ml,对头孢呋辛、头孢克洛和头孢噻肟的MIC90分别为4、8、1μg/ml,对四环素的MIC90为16μg/ml;环丙沙星为最敏感的抗菌药。(2)80株卡他莫拉菌bro基因分型结果:6株(7.5%)bro阴性,55株(68.8%)bro1阳性,19株(23.8%)bro2阳性。其中有2株bro基因阴性经Nitrocefin纸片法检测,β内酰胺酶结果为阳性,其他菌株基因检测与产酶结果一致。(3)bro1阳性菌株对氨苄西林、头孢克洛的MIC90值与bro2阳性菌株相比,有不同程度的升高。结论我国儿童携带的卡他莫拉菌产酶率高,对氨苄西林高度耐药。目前应加强该菌对头孢类和四环素的耐药监测。限制性内切酶分析方法在检测bro基因、筛选卡他莫拉菌对β内酰胺类抗生素的耐药及分子流行病学调查方面有一定的应用价值。 Objective To distinguish BRO β-lactamase by use of restriction endonuclease analysis and investigate antibacterial agents resistance of Moraxella catarrhalis(M. Catarrhalis) with different BRO β-lactamases .Methods Nasopharyngeal swabs of children with respiratory tract infections from the outpatient department of Beijing Children's Hospital were cultured for isolating M.Catarrhalis. BSAC(british society for antimicrobial chemotherapy) agar diffusion test was used to determine antibacterial agents resistance of M.Catarrhalis.Nitrocefin disk was used to detect β-lactamase. Restriction endonuclease analysis was used to distinguish BRO β-lactamases . Antibacterial agents resistance of M. Catarrhalis with different bro genes was compared.Results (1)95.0% of the 80 strains were beta-lactamase positive. MIC 90 of ampicillin was 32 μg/ml and MIC 90 of cefuroxime,cefaclor and cefotaxime were 4 μg/ml,8μg/ml and 1μg/ml respectively,MIC 90 of tetracycline was 16μg/ml. Among the antibacterial agents,ciprofloxacin was the most sensintive agent.(2)Among 80 strains,6(7.5%) Strains were bro negative,55(68.8%) were bro-1 positive,19(23.8%)were bro-2 positive。Except 2 strains,the results of β-lactamases were same as the results of nitrocefin disk and restriction endonuclease analysis.(3)Compared with bro-2 positive strains,the MIC value of ampicillin and cefaclor for bro-1 positive strains were higher.Conclusions Antibacterial agents resistance of M. Catarrhalis to ampicillin was sierous in China. It should be strengthened to monitor antibacterial agents resistance of M.Catarrhalis. Restriction endonuclease analysis can play an important role on characterizing bro genes,evaluating antibacterial agents resistance of Moraxella Catarrhalis to β-lactam and investigating molecular epideminology
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2005年第6期645-647,共3页 Chinese Journal of Laboratory Medicine
  • 相关文献

参考文献6

  • 1Verduin CM, Hol C, Fleer A, et al. Moraxella catarrhalis:from emerging to established pathogen. Clin Microbiol Rev ,2002,15:125-144.
  • 2Andrews J M. Determination of minimum inhibitory concentrations. J Antimicrob Chemother, 2001,48 Suppl S1:5-16.
  • 3Du Plessis M. Rapid discrimination between BRO beta-lactamases from clinical isolates of Moraxella catarrhalis using restrion endonuclease analysis. Diagn Microbiol Infect Dis,2001,39,65-67.
  • 4Johnson DM, Sader H S ,Fritsche TR, et al. Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents:five-year report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis,2003,47,373-376.
  • 5Bootsma H,Aerts PC,Posthuma G,et al. Moraxella(Branhamella)catarrhalis BRO beta-lactamase:a lippoprotein of gram-positive origin?J Bacteriol,1999,181:5090-5093.
  • 6Mcgregor K, Chang BJ, Mee B J. Moraxella Catarrhalis :Clinical significance ,antimicrobial susceptibility and BRO-lactamases. J Clin Microbiol Infect Dis,1998,17:219.

同被引文献91

  • 1李万华,张泓,孔菁,王春,孙燕.儿童患者中分离的铜绿假单胞菌耐药性分析[J].中国感染与化疗杂志,2009,9(1):63-66. 被引量:2
  • 2李春霞,方怀天,毛菊秀,赵霞,潘万俊,李辉.儿童呼吸道卡他莫拉菌感染的防治[J].职业与健康,2004,20(7):137-138. 被引量:2
  • 3朱德妹,汪复,张婴元.2004年上海地区细菌耐药性监测[J].中国抗感染化疗杂志,2005,5(4):195-200. 被引量:227
  • 4汪玲,陆权,王传清,邓秋莲,刘岚,甄景慧,张泓,王艺,黄勇,陈沅,杨永弘,沈叙庄.2000~2004年京沪穗渝5家儿童医院革兰阳性球菌耐药情况分析[J].中国循证儿科杂志,2006,1(2):113-121. 被引量:36
  • 5Leesik H, Ani U, Juhani A, et al. Microbial pathogens of adult community-acquired pneumonia in Southern Estonia [J ]. Medicina, 2006,42 (5) : 384-394 [ Lithuania ].
  • 6Wirth T, Morelli G, Kusecek B, et al. The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis [J ]. Genome Res, 2007,17 ( 11 ) : 1647-1656.
  • 7Karlowsky JA, Thornsberry C, Critchley IA, et al. Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae , and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001 - 2002 TRUST studies in the United States [J]. Autimicrob Agents Chemother, 2003,47 (6) : 1790-1797.
  • 8Verduin CM, Hot C, Fleer A, et ol. Moraxella catarrhalis: from emerging to established pathogen [J]. Clin Microbiol Rev,2002,15( 1 ) : 125-144.
  • 9du Plessis M. Rapid discrimination between BRO betalactamases from clinical isolates of Moraxella catarrhalis using restriction endonuclease analysis [J]. Diagn Microbiol Infect Dis, 2001,39 ( 1 ) : 65-67.
  • 10Bootsma HJ, vanDijk H, Verhoef J, et al. Molecular characterization of the BRO beta-lactamases of Moraxella (Branhamella) catarrhalis [J]. Antimicrob Agents Chemother, 1996,40 (4) : 966-972.

引证文献6

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部